BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19549259)

  • 21. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors.
    Safarinejad MR
    J Nephrol; 2009; 22(1):99-108. PubMed ID: 19229824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The choice of estimating equations for glomerular filtration rate significantly affects the prevalence of chronic kidney disease in a multi-ethnic population during health screening.
    Teo BW; Ng ZY; Li J; Saw S; Sethi S; Lee EJ
    Nephrology (Carlton); 2009 Sep; 14(6):588-96. PubMed ID: 19712259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses.
    Lucas SM; Nuss G; Stern J; Lotan Y; Sagalowsky AI; Cadeddu JA; Raj GV
    Cancer; 2008 Nov; 113(10):2681-6. PubMed ID: 18853420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
    BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
    Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
    Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients.
    van Gestel YR; Chonchol M; Hoeks SE; Welten GM; Stam H; Mertens FW; van Domburg RT; Poldermans D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2763-7. PubMed ID: 19369691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease.
    Essig M; Escoubet B; de Zuttere D; Blanchet F; Arnoult F; Dupuis E; Michel C; Mignon F; Mentre F; Clerici C; Vrtovsnik F
    Nephrol Dial Transplant; 2008 Jan; 23(1):239-48. PubMed ID: 17704109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors.
    Jeon HG; Jeong IG; Lee JW; Lee SE; Lee E
    Urology; 2009 Nov; 74(5):1064-8. PubMed ID: 19758688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Cannibalism' (cell phagocytosis) does not differentiate reactive renal tubular cells from urothelial carcinoma cells.
    Ohsaki H; Haba R; Matsunaga T; Nakamura M; Kiyomoto H; Hirakawa E
    Cytopathology; 2009 Aug; 20(4):224-30. PubMed ID: 19563449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CKD stage-to-stage progression in native and transplant kidney disease.
    Kukla A; Adulla M; Pascual J; Samaniego M; Nanovic L; Becker BN; Djamali A
    Nephrol Dial Transplant; 2008 Feb; 23(2):693-700. PubMed ID: 17881429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
    Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
    BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5.
    Murtagh FE; Marsh JE; Donohoe P; Ekbal NJ; Sheerin NS; Harris FE
    Nephrol Dial Transplant; 2007 Jul; 22(7):1955-62. PubMed ID: 17412702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance.
    Bassilios N; Martel P; Godard V; Froissart M; Grünfeld JP; Stengel B;
    Nephrol Dial Transplant; 2008 Feb; 23(2):562-5. PubMed ID: 17999992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired vascular reactivity in patients with chronic kidney disease.
    Tetzner F; Scholze A; Wittstock A; Zidek W; Tepel M
    Am J Nephrol; 2008; 28(2):218-23. PubMed ID: 17960060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD.
    Szeto CC; Chow KM; Lai KB; Szeto CY; Chan RW; Kwan BC; Chung KY; Li PK; Lai FM
    Am J Kidney Dis; 2006 Apr; 47(4):578-86. PubMed ID: 16564935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
    Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.